Sinar Daily on MSN27m
Seven-year trial shows 48 per cent survival with dual immunotherapyPatients with advanced melanoma that had spread to the brain were previously expected to survive for only 16 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback